Perspectives on the SSCI Torture Report, and More from CRS
New reports from the Congressional Research Service that Congress has not made publicly available include the following.
Perspectives on the Senate Select Committee on Intelligence (SSCI) “Torture Report” and Enhanced Interrogation Techniques: In Brief, February 10, 2015
U.S. Sanctions on Russia: Economic Implications, February 4, 2015
Alien Removals and Returns: Overview and Trends, February 3, 2015
A Guide to Describing the Income Distribution, February 5, 2015
The Measles: Background and Federal Role in Vaccine Policy, February 9, 2015
Bee Health: The Role of Pesticides, February 9, 2015
Newly updated versions of prior CRS reports that Congress has also withheld from online public distribution include these.
The United States and Europe: Current Issues, February 3, 2015
Yemen: Background and U.S. Relations, February 11, 2015
The Presidential Records Act: Background and Recent Issues for Congress, December 31, 2014
Trafficking in Persons in Latin America and the Caribbean, February 11, 2015
Monetary Policy and the Federal Reserve: Current Policy and Conditions, February 9, 2015
Tailoring the Patent System for Specific Industries, February 6, 2015
The Global Climate Change Initiative (GCCI): Budget Authority and Request, FY2010-FY2016, February 6, 2015
EPA Regulation of Greenhouse Gases: Congressional Responses and Options, February 5, 2015
Evaluating the “Past Performance” of Federal Contractors: Legal Requirements and Issues, February 5, 2015
The Target and Other Financial Data Breaches: Frequently Asked Questions, February 4, 2015
Domestic Food Assistance: Summary of Programs, February 4, 2015
Terminating Contracts for the Government’s Convenience: Answers to Frequently Asked Questions, February 3, 2015
The Federal Acquisition Regulation (FAR): Answers to Frequently Asked Questions, February 3, 2015
Offender Reentry: Correctional Statistics, Reintegration into the Community, and Recidivism, January 12, 2015
Crime and Forfeiture, January 22, 2015
As surrogate markers are increasingly being accepted by FDA to support approval of new drugs and biologics, it is imperative that patients and clinicians understand whether such novel endpoints are reflective of meaningful clinical benefits.
The Secretary of Health and Human Services should launch a Department-wide initiative to reduce wasteful spending on health services, drugs, and ineffective medical devices, saving many lives as well as billions of dollars annually.
Now that the One Big Beautiful Bill is law, the elimination of clean energy tax credits will cause a nation of higher energy bills – even for consumers and states that aren’t using clean energy.
Bureaucracy significantly hinders federally funded scientific research, diverting scientists’ time from discovery to low-value administrative tasks.